Free regulatory intelligence — powered by Certivo
Substance AdditionLiveLive RegulationSubstance Addition

Nevada Board of Pharmacy adopted NAC 453.510 amendment adding ethylphenidate and 2‑methyl AP‑237 to Schedule I

Nevada Uniform Controlled Substances Act (NRS 453 / NAC 453)Nevada State Board of PharmacyUS, Nevada
Announced

Jan 21, 2026

Description

An informational statement for an adopted Nevada State Board of Pharmacy regulation reports an amendment to NAC 453.510 (Schedule I) adding ethylphenidate and 2‑methyl AP‑237 to Nevada’s Schedule I list. These additions expand substances regulated as Schedule I under Nevada’s Uniform Controlled Substances Act implementation, affecting compliance for any organization potentially encountering these substances (e.g., prohibitions and controls related to possession, distribution, and enforcement consequences). The document states the change is intended to keep Nevada in conformity with federal controlled substance scheduling.

Get compliance alerts for Nevada Uniform Controlled Substances Act (NRS 453 / NAC 453)

Certivo tracks regulatory changes and automates compliance workflows for your products.

Start Free Trial